Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

FLUCONAZOLE

All products: general benefit

Other products in the same Health Canada class (J02A, J02AC) — coverage varies; not interchangeable

  • Itraconazole (Sporanox): general benefit, Limited Use 570, Not a benefit
  • Voriconazole (Vfend): limited Use 399
  • Posaconazole (Posanol): not a benefit
  • Amphotericin b (Fungizone): general benefit
  • Ketoconazole (Nizoral): general benefit, Not a benefit
  • Caspofungin (Cancidas): not a benefit

1 more in the class list below

PMS-Fluconazole · DIN 02245643 · 50mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Fluconazole · DIN 02245643 Manufacturer: Pharmascience Inc.; listing date 2003-01-30 Daily cost (source): $2.5808 Health Canada: Marketed since 2002-06-05 · brand PMS-FLUCONAZOLE · ATC J02AC01 FLUCONAZOLE · form Tablet · route Oral · ingredients FLUCONAZOLE 50 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Fluconazole: Formulary list price $1.2904/unit (unit not stated in source; not the patient's cost)

Ministry pays: $1.2904 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69743 · Verify on the e-Formulary ↗ (DIN 02245643)

Source record
DIN 02245643: PMS-Fluconazole Raw flags: sec3=Y Item: 081204023; group id 9; item number 0011; lccId 00002; manufacturer id PMS Source form: Tab; strength: 50mg Recorded listing: General benefit Source prices (unrounded): $1.2904; ministry $1.2904 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02245643 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=69743
Interchangeable products
Act Fluconazole · DIN 02281260 · $1.2904 Apo-Fluconazole · DIN 02237370 · $1.2904 Diflucan · DIN 00891800 · not recorded Fluconazole · DIN 02517396 · $1.2904 Fluconazole · DIN 02534886 · $1.2904 Mylan-Fluconazole · DIN 02245292 · $1.2904 Teva-Fluconazole · DIN 02236978 · $1.2904
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (08:12:04 Antifungals) and how they are covered

Matched class: 08:12:04 Antifungals

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: AMPHOTERICIN B Some products covered without a code (check the product listing): ITRACONAZOLE, KETOCONAZOLE, NYSTATIN, TERBINAFINE HCL 08:12:04 Antifungals

ITRACONAZOLE

· 5 products · General benefit (2), Listed, not a benefit (1), Limited Use, codes 570 (2) · strengths: 100mg, 10mg/mL · Cap, Oral Sol

VORICONAZOLE

· 6 products · Limited Use, codes 399 · strengths: 50mg, 200mg · Tab

POSACONAZOLE

· 7 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 100mg, 40mg/mL · DR Tab, O/L

AMPHOTERICIN B

· 1 products · General benefit · strengths: · Inj Pd-50mg Pk

KETOCONAZOLE

· 3 products · Listed, not a benefit (1), General benefit (2) · strengths: 200mg · Tab

CASPOFUNGIN ACETATE

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mg/Vial · Inj-Vial Pk

MICAFUNGIN SODIUM

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 50mg/Vial, 100mg/Vial · Inj Pd-10mL Vial Pk

NYSTATIN

· 3 products · Listed, not a benefit (1), General benefit (2) · strengths: 100000U/mL · O/L

TERBINAFINE HCL

· 8 products · Listed, not a benefit (1), General benefit (7) · strengths: 250mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:04
Full class listing Related classes: 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:16 Penicillins, 08:12:24 Tetracyclines, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1 INDICATIONS Treatment DIFLUCAN (fluconazole) is indicated for the treatment of: 1. Oropharyngeal and esophageal candidiasis. DIFLUCAN is also effective for the treatment of serious systemic candidal infections, including urinary tract infection, peritonitis, and pneumonia. 2. Cryptococcal meningitis. 3. Prevention of the recurrence of cryptococcal meningitis in patients with acquired immunodeficiency syndrome (AIDS). Specimens for fungal culture and other relevant laboratory studies (serology, histopathology) should be obtained prior to therapy to isolate and identify causative organisms. Therapy may be instituted before the results of the cultures and other laboratory studies are known; however, once these results become available, anti-infective therapy should be adjusted accordingly. Prophylaxis DIFLUCAN is also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy. 1.1 Pediatrics (<18 years of age) Based on the data submitted and reviewed by Health Canada, the safety and efficacy of DIFLUCAN in pediatric patients ha… https://pdf.hres.ca/dpd_pm/00085459.PDF PM date: 2026-07-21 Source product: DIFLUCAN; DIN 02024152; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.